Yufen Xu

560 total citations
48 papers, 415 citations indexed

About

Yufen Xu is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Yufen Xu has authored 48 papers receiving a total of 415 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Surgery, 21 papers in Pulmonary and Respiratory Medicine and 17 papers in Molecular Biology. Recurrent topics in Yufen Xu's work include Kawasaki Disease and Coronary Complications (31 papers), Coronary Artery Anomalies (20 papers) and Cancer-related molecular mechanisms research (12 papers). Yufen Xu is often cited by papers focused on Kawasaki Disease and Coronary Complications (31 papers), Coronary Artery Anomalies (20 papers) and Cancer-related molecular mechanisms research (12 papers). Yufen Xu collaborates with scholars based in China, United States and Canada. Yufen Xu's co-authors include Di Che, Xiaoqiong Gu, Lei Pi, Li Zhang, Hong-Ling Jia, Ping Huang, Zhaoliang Lu, Yaqian Tan, Jun Bai and Zhuoya Wang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Yufen Xu

47 papers receiving 410 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yufen Xu China 12 200 171 132 130 83 48 415
Lucyna Rudnicka‐Sosin Poland 11 149 0.7× 68 0.4× 61 0.5× 60 0.5× 42 0.5× 37 385
Jianping Sun China 6 172 0.9× 95 0.6× 108 0.8× 234 1.8× 63 0.8× 9 430
Fredy Omar Beltrán‐Anaya Mexico 11 241 1.2× 47 0.3× 197 1.5× 31 0.2× 44 0.5× 21 360
Zhengfu He China 10 120 0.6× 48 0.3× 62 0.5× 85 0.7× 66 0.8× 43 288
Ruaa Al‐Qazazi Canada 7 151 0.8× 29 0.2× 40 0.3× 125 1.0× 63 0.8× 9 310
Noemy Starita Italy 9 217 1.1× 55 0.3× 169 1.3× 44 0.3× 26 0.3× 22 452
Shota Fujimoto Japan 9 138 0.7× 29 0.2× 59 0.4× 114 0.9× 23 0.3× 20 297
Charalampos Moschos Greece 13 108 0.5× 41 0.2× 75 0.6× 265 2.0× 86 1.0× 27 477
Nathalie Niyonzima Norway 7 177 0.9× 90 0.5× 16 0.1× 40 0.3× 258 3.1× 12 428
Yuriko Terada United States 11 46 0.2× 149 0.9× 27 0.2× 92 0.7× 77 0.9× 38 330

Countries citing papers authored by Yufen Xu

Since Specialization
Citations

This map shows the geographic impact of Yufen Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yufen Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yufen Xu more than expected).

Fields of papers citing papers by Yufen Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yufen Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yufen Xu. The network helps show where Yufen Xu may publish in the future.

Co-authorship network of co-authors of Yufen Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Yufen Xu. A scholar is included among the top collaborators of Yufen Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yufen Xu. Yufen Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Ping, Zhenhui Wang, Yufen Xu, & Meirong Wu. (2025). Mechanism underlying the role of the circRNA OMA1/miR-654-3p/RAF1 axis in children with inflammatory bowel disease. Cytotechnology. 77(2). 42–42. 1 indexed citations
2.
3.
Yu, Hongyan, Yufen Xu, Kaining Chen, et al.. (2022). Association between Rab31/rs9965664 polymorphism and immunoglobulin therapy resistance in patients with Kawasaki disease. Frontiers in Cardiovascular Medicine. 9. 944508–944508. 2 indexed citations
4.
Xu, Yufen, et al.. (2022). The Associated of the Risk of IVIG Resistance in Kawasaki Disease with ZNF112 Gene and ZNF180 Gene in a Southern Chinese Population. Journal of Inflammation Research. Volume 15. 5053–5062. 4 indexed citations
5.
Zhang, Linyuan, Hongyan Yu, Yufen Xu, et al.. (2022). The rs7404339 AA Genotype in CDH5 Contributes to Increased Risks of Kawasaki Disease and Coronary Artery Lesions in a Southern Chinese Child Population. Frontiers in Cardiovascular Medicine. 9. 760982–760982. 4 indexed citations
6.
Yu, Hongyan, Kaining Chen, Yufen Xu, et al.. (2022). The EIF2AK4/rs4594236 AG/GG Genotype Is a Hazard Factor of Immunoglobulin Therapy Resistance in Southern Chinese Kawasaki Disease Patients. Frontiers in Genetics. 13. 868159–868159. 2 indexed citations
7.
Xu, Yufen, Hongyan Yu, Lei Pi, et al.. (2021). Association study of miR‐149, miR‐196a2, and miR‐499a polymorphisms with coronary artery aneurysm of Kawasaki disease in southern Chinese population. The Journal of Gene Medicine. 24(4). e3405–e3405. 7 indexed citations
8.
Che, Di, et al.. (2021). The SERPINA4 rs2070777 AA Genotype is Associated with an Increased Risk of Recurrent Miscarriage in a Southern Chinese Population. International Journal of Women s Health. Volume 13. 111–117. 5 indexed citations
9.
Che, Di, et al.. (2021). The lncRNA ANRIL Gene rs2151280 GG Genotype is Associated with Increased Susceptibility to Recurrent Miscarriage in a Southern Chinese Population. Journal of Inflammation Research. Volume 14. 2865–2872. 8 indexed citations
10.
Zhang, Linyuan, Hongyan Yu, Jinqing Li, et al.. (2021). Protective Effect of TNFRSF11A rs7239667 G > C Gene Polymorphism on Coronary Outcome of Kawasaki Disease in Southern Chinese Population. Frontiers in Genetics. 12. 691282–691282. 2 indexed citations
11.
Wu, Zhiyuan, et al.. (2021). The lncRNA CCAT2 Rs6983267 G Variant Contributes to Increased Sepsis Susceptibility in a Southern Chinese Population. Infection and Drug Resistance. Volume 14. 2969–2976. 2 indexed citations
12.
Xu, Yufen, Di Che, Yaqian Tan, et al.. (2020). The rs1051931 G>A Polymorphism in the PLA2G7 Gene Confers Resistance to Immunoglobulin Therapy in Kawasaki Disease in a Southern Chinese Population. Frontiers in Pediatrics. 8. 338–338. 3 indexed citations
13.
Che, Di, Yufen Xu, Lei Pi, et al.. (2019). The lncRNA MALAT1 rs619586 G Variant Confers Decreased Susceptibility to Recurrent Miscarriage. Frontiers in Physiology. 10. 385–385. 27 indexed citations
14.
Pi, Lei, et al.. (2018). A PEAR1 polymorphism (rs12041331) is associated with risk of coronary artery aneurysm in Kawasaki disease. Annals of Human Genetics. 83(1). 54–62. 10 indexed citations
15.
Che, Di, et al.. (2018). ABCC4 Variants Modify Susceptibility to Kawasaki Disease in a Southern Chinese Population. Disease Markers. 2018. 1–7. 9 indexed citations
16.
Che, Di, Jiawen Li, Lei Pi, et al.. (2018). The rs1625579 T&gt;G polymorphism in the <em>miRNA-137</em> gene confers a risk of early-onset Kawasaki disease in a southern Chinese population. Infection and Drug Resistance. Volume 11. 1055–1060. 11 indexed citations
17.
Jia, Hong-Ling, Li Zhang, Xuejuan Gao, et al.. (2017). Sets of serum exosomal microRNAs as candidate diagnostic biomarkers for Kawasaki disease. Scientific Reports. 7(1). 44706–44706. 33 indexed citations
18.
Zhang, Li, Wei Wang, Jun Bai, et al.. (2016). Proteomic analysis associated with coronary artery dilatation caused by Kawasaki disease using serum exosomes. Revista Portuguesa de Cardiologia. 35(5). 265–273. 13 indexed citations
19.
Jia, Hong-Ling, et al.. (2014). MicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease. BMC Infectious Diseases. 14(1). 506–506. 36 indexed citations
20.
Zou, Ying, et al.. (2014). Study on Chinese medicine syndrome of colorectal carcinoma in perioperative period. Chinese Journal of Integrative Medicine. 21(3). 183–187. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lucyna Rudnicka‐Sosin Breakdown of academic impact, for papers by Jianping Sun Breakdown of academic impact, for papers by Fredy Omar Beltrán‐Anaya Breakdown of academic impact, for papers by Zhengfu He Breakdown of academic impact, for papers by Ruaa Al‐Qazazi Breakdown of academic impact, for papers by Noemy Starita Breakdown of academic impact, for papers by Shota Fujimoto Breakdown of academic impact, for papers by Charalampos Moschos Breakdown of academic impact, for papers by Nathalie Niyonzima Breakdown of academic impact, for papers by Yuriko Terada
Rankless by CCL
2026